Ty Johnson

Running Back

Age: 28
Free Agency: 2027 (UFA)
Accrued Seasons: 6
  • 2025 Salary Cap Charge: $1,975,000 (0.73% of cap)
  • 2025 Cash Payout: $2,475,000 (0.78% of spending)
  • 2025 Cash to Cap Ratio: 1.25
  • Contract Value: $5,000,000 ($2,500,000 APY)
  • Fully Guaranteed Money: $2,490,000
  • Contract Ranking: 30/142 at RB

Current Contract

(UFA, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202528$1,170,000$500,000$255,000$50,000$1,170,000$1,975,0000.7%
202629$2,220,000$500,000$255,000$50,000$320,000$3,025,0001.0%
Total$3,390,000$1,000,000$510,000$100,000$1,490,000$5,000,000

Contract Notes

Ty Johnson signed a one year contract with the Jets. $250,000 is guaranteed.

Cash Flows

- fully earned money
- unearned or partially earned money
$2.5M
$5M
20252026
Cash Due$2,475,000$2,525,000
Running Cash$2,475,000$5,000,000
Career Earnings: $6,341,656
Career APY: $1,056,943
Potential Earnings: $10,050,938
Total Guarantees: $3,752,612
Largest Cash Payment: $2,525,000 (2026)
Largest Cap Number: $3,025,000 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
JetsDraftedExpired20194$2,692,556$673,139$172,556$2,370,88288.1%$790,294
LionsDraftedClaimed20194$2,692,556$673,139$172,556$667,55624.8%$667,556
JetsUFATerminated20231$1,232,500$1,232,500$250,000$00.0%$0
BillsSFATerminated20231$1,080,000$1,080,000$0$00.0%$0
BillsPracticeRenegotiated20231$289,800$289,800$0$00.0%$0
BillsSFAExpired20231$1,080,000$1,080,000$0$720,00066.7%$720,000
BillsUFAExpired20241$1,292,500$1,292,500$667,500$1,292,500100.0%$1,292,500
BillsUFAActive20252$5,000,000$2,500,000$2,490,000$1,000,00020.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Jets3$2,445,882$815,294$2,370,8820.0%$75,0000.0%
Lions1$786,674$786,674$538,1390.0%$248,5350.0%
Bills2$3,109,100$1,554,550$1,779,1670.0%$96,6000.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Lions$495,000$43,139$0$0$0$538,1390.3%$667,556
2020Jets$675,000$0$0$0$0$555,8820.3%$555,882
2021Jets$850,000$0$0$0$0$850,0000.4%$850,000
2022Jets$965,000$0$0$0$0$965,0000.5%$965,000
2023Bills$1,080,000$0$0$0$0$626,6670.3%$720,000
2024Bills$1,125,000$167,500$0$0$500,000$1,152,5000.4%$1,292,500
2025Bills$1,170,000$500,000$255,000$50,000$1,170,000$1,975,0000.7%$2,475,000
2026Bills$2,220,000$500,000$255,000$50,000$320,000$3,025,0001.0%$2,525,000
Total$8,580,000$1,210,639$510,000$100,000$1,990,000$9,688,188$10,050,938
Dead Money History
TeamYearCap ChargeCash Paid
Lions2020$162,257$119,118
Lions2021$86,278$0
Jets2023$75,000$75,000
Bills2023$96,600$96,600
Total$420,135$290,718

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2019160028.8%25.2%632734.30241094.5011
2020130217.6%17.7%542544.7116996.2100
2021160137.7%20.3%612383.923437210.9200
2022170015.5%41.7%301605.3112887.3000
202310107.8%15.1%122.00000.0000
2024170029.0%25.3%412135.211828415.8300

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,723,000$2,500,000
Injury Adjusted$1,723,000$2,500,000
test
OTC Valuation $2.5M $5M $7.5M $10M $12.5M APY $3.4M $6.9M $10.3M $13.7M $17.2M $7,062,000 $5,489,636

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.